NO952411D0 - Midler for behandling av metaboliske bensykdommer - Google Patents

Midler for behandling av metaboliske bensykdommer

Info

Publication number
NO952411D0
NO952411D0 NO952411A NO952411A NO952411D0 NO 952411 D0 NO952411 D0 NO 952411D0 NO 952411 A NO952411 A NO 952411A NO 952411 A NO952411 A NO 952411A NO 952411 D0 NO952411 D0 NO 952411D0
Authority
NO
Norway
Prior art keywords
treatment
bone disorders
metabolic bone
metabolic
disorders
Prior art date
Application number
NO952411A
Other languages
English (en)
Other versions
NO952411L (no
Inventor
Masakazu Katoh
Kazuyuki Kitamura
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of NO952411D0 publication Critical patent/NO952411D0/no
Publication of NO952411L publication Critical patent/NO952411L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO952411A 1994-06-17 1995-06-16 Midler for behandling av metaboliske bensykdommer NO952411L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6135275A JPH083058A (ja) 1994-06-17 1994-06-17 新規な骨代謝疾患治療剤

Publications (2)

Publication Number Publication Date
NO952411D0 true NO952411D0 (no) 1995-06-16
NO952411L NO952411L (no) 1995-12-18

Family

ID=15147903

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952411A NO952411L (no) 1994-06-17 1995-06-16 Midler for behandling av metaboliske bensykdommer

Country Status (10)

Country Link
US (1) US5726148A (no)
EP (1) EP0687470A3 (no)
JP (1) JPH083058A (no)
KR (1) KR960000248A (no)
AU (1) AU697136B2 (no)
CA (1) CA2152023A1 (no)
FI (1) FI952953A (no)
HU (1) HU218947B (no)
NO (1) NO952411L (no)
TW (1) TW496740B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020028798A1 (en) * 1995-12-12 2002-03-07 Omeros Medical Systems Irrigation solution and method for inhibition of pain and inflammation
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
US7029861B1 (en) 1998-09-15 2006-04-18 Board Of Regents, The University Of Texas System LPS-response gene compositions and methods
JP3755564B2 (ja) 1999-05-24 2006-03-15 株式会社村田製作所 圧電共振部品及びその製造方法
CN101850120A (zh) 1999-07-21 2010-10-06 奥默罗斯公司 用于抑制疼痛,炎症和软骨退化的溶液及方法
WO2002066063A1 (fr) * 2001-02-23 2002-08-29 Nippon Organon K.K. Traitements de maladies osseuses metaboliques

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004838A1 (en) * 1987-11-25 1989-06-01 Immunex Corporation Interleukin-1 receptors
US4968607A (en) * 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5319071A (en) * 1987-11-25 1994-06-07 Immunex Corporation Soluble interleukin-1 receptors
AU6030990A (en) * 1989-07-07 1991-02-06 E.I. Du Pont De Nemours And Company Soluble human b-cell interleukin-1 receptor
EP0474141B1 (en) * 1990-09-03 1996-01-31 Kuraray Co., Ltd. Peptide or its salts
WO1992011359A1 (en) * 1990-12-20 1992-07-09 University Of Pittsburgh Of The Commonwealth System Of Higher Education A truncated interleukin-1 receptor gene for the treatment of arthritis

Also Published As

Publication number Publication date
NO952411L (no) 1995-12-18
EP0687470A2 (en) 1995-12-20
FI952953A0 (fi) 1995-06-15
FI952953A (fi) 1995-12-18
KR960000248A (ko) 1996-01-25
TW496740B (en) 2002-08-01
AU697136B2 (en) 1998-09-24
JPH083058A (ja) 1996-01-09
CA2152023A1 (en) 1995-12-18
EP0687470A3 (en) 1996-06-19
HU9501779D0 (en) 1995-08-28
US5726148A (en) 1998-03-10
AU2171695A (en) 1996-01-04
HU218947B (hu) 2001-01-29
HUT72054A (en) 1996-03-28

Similar Documents

Publication Publication Date Title
IL121170A0 (en) Compositions for the treatment of dermatological disorders
NO982172D0 (no) Anvendelse av epinastin for behandling av smerter
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
NO965377L (no) Indolinonforbindelser for behandling av sykdommer
IL108772A0 (en) Treatment of rhinitis by biostimulative illumination
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
NO20005884L (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
NO20001869D0 (no) Fremgangsmõte for behandling av Alzheimerssykdom
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20012106L (no) Middel for behandling av forstyrrelser i benmetabolismen
EP1039883A4 (en) METHOD FOR TREATING APOLIPOPROTEIN E CONDITIONAL DISEASES
ID23528A (id) Pengobatan terapeutik untuk gangguan kulit
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
NO984432L (no) FremgangsmÕte for behandling av migrenesmerte
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
NO952411D0 (no) Midler for behandling av metaboliske bensykdommer
NO974569L (no) Benzamider for behandling av neurodegenerative forstyrrelser
NO982562D0 (no) Sammensetning for behandling av smerte
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS
EP0755262A4 (en) PNEUMOPATHY TREATMENT COMPOSITION
NO962812D0 (no) Fremgangsmåte for behandling av nervebetennelse
NO964291D0 (no) Fremgangsmåte for behandling av allergisk rinitt
NO984190D0 (no) Fremgangsmåte for behandling av insomnia

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application